| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0076 | 0.9 |